EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

X- ray crystallography reveals the mechanism of SARS-CoV-2 PLpro dimerization mediated by a DNA-encoded library screening hit

Orville Pemberton, Amanda M Nevins, Thomas E Frederick, Emily Nicholl, Myron Srikumaran, Jun Chen, Alla Korepanova, Vincent Stoll, Andrew Petros, Sujatha Gopalakrishnan, Justin Dietrich, Liliam Rios Cordero und 3 weitere

Structural Dynamics · 01.09.2025 · 12 (5_Supplement) · A22-A22

DOI: 10.1063/4.0000814 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Structural Dynamics, online erschienen am 27.10.2025. Verfasst von Orville Pemberton und 14 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic caused by SARS-CoV-2 has devastated global health, revealing an urgent need for novel therapeutics. The papain-like protease (PLpro) is one of two proteases encoded by SARS-CoV-2, representing an attractive drug target due to its dual roles in viral replication and host immune suppression. We employed a DNA-encoded library (DEL) screen to reveal starting points for our PLpro hit discovery campaign. These efforts led to the identification of compound 1, a diarylmethanol-containing substructure with a unique binding mode that induces PLpro dimerization. Compound 1 demonstrates potent activities in both a biochemical ubiquitin-rhodamine and antiviral HeLa-ACE2 cell assays. An X- ray co-crystal structure of compound 1 bound to PLpro solved to 2.0 Å showed that two molecules of compound 1 glues two monomers of PLpro together via binding to the BL2 groove of one monomer and the Ubl/thumb domain of the other. Several molecular interactions were observed between compound 1 and PLpro including hydrophobic interactions and several hydrogen-bonds across both monomers. The molecular glue-like properties of compound 1 on PLpro were further validated in solution with analytical SEC and protein-detect 2D-NMR. Subsequent rounds of SAR led to compound 2, which has comparable biochemical and antiviral activities and demonstrated the same dimerization mechanism of PLpro as seen in a 1.8 Å X-ray co-crystal structure. In summary, we have identified a new series of PLpro inhibitors with a novel mechanism of SARS-CoV-2 inhibition, providing a promising start for the discovery of antivirals for treating COVID-19.

Zitieren

APA

Pemberton, O., Nevins, A. M., Frederick, T. E., Nicholl, E., Srikumaran, M., Chen, J., Korepanova, A., Stoll, V., Petros, A., Gopalakrishnan, S., Dietrich, J., Cordero, L. R., Hardee, D. J., Ng, T. I., & Sun, C. (2025). X- ray crystallography reveals the mechanism of SARS-CoV-2 PLpro dimerization mediated by a DNA-encoded library screening hit. Structural Dynamics, 12(5_Supplement), A22-A22. https://doi.org/10.1063/4.0000814

Vancouver

Pemberton O, Nevins AM, Frederick TE, Nicholl E, Srikumaran M, Chen J, et al. X- ray crystallography reveals the mechanism of SARS-CoV-2 PLpro dimerization mediated by a DNA-encoded library screening hit. Structural Dynamics. 2025;12(5_Supplement):A22-A22. doi:10.1063/4.0000814

BibTeX
@article{Pemberton2025,
  author = {Pemberton, Orville and Nevins, Amanda M and Frederick, Thomas E and Nicholl, Emily and Srikumaran, Myron and Chen, Jun and Korepanova, Alla and Stoll, Vincent and Petros, Andrew and Gopalakrishnan, Sujatha and Dietrich, Justin and Cordero, Liliam Rios and Hardee, David J and Ng, Teresa I and Sun, Chaohong},
  title = {X- ray crystallography reveals the mechanism of SARS-CoV-2 PLpro dimerization mediated by a DNA-encoded library screening hit},
  journal = {Structural Dynamics},
  year = {2025},
  volume = {12},
  number = {5_Supplement},
  pages = {A22--A22},
  doi = {10.1063/4.0000814}
}
Kostenlos starten →